Prathipati Priyanka, Metreveli Naira, Nandi Shyam Sundar, Tyagi Suresh C, Mishra Paras K
Department of Cellular and Integrative Physiology, University of Nebraska Medical Center Omaha, NE, USA.
Department of Physiology and Biophysics, University of Louisville Louisville, KY, USA.
Front Physiol. 2016 Mar 15;7:93. doi: 10.3389/fphys.2016.00093. eCollection 2016.
Elevated expression and activity of matrix metalloproteinase-9 (MMP9) and decreased contractility of cardiomyocytes are documented in diabetic hearts. However, it is unclear whether MMP is involved in the regulation of contractility of cardiomyocytes in diabetic hearts. In the present study, we tested the hypothesis that MMP9 regulates contractility of cardiomyocytes in diabetic hearts, and ablation of MMP9 prevents impaired contractility of cardiomyocytes in diabetic hearts. To determine the specific role of MMP9 in cardiomyocyte contractility, we used 12-14 week male WT (normoglycemic sibling of Akita), Akita, and Ins(2+∕-)/MMP9(-∕-) (DKO) mice. DKO mice were generated by cross-breeding male Ins2(+∕-) Akita (T1D) with female MMP9 knockout (MMP9(-∕-)) mice. We isolated cardiomyocytes from the heart of the above three groups of mice and measured their contractility and calcium transients. Moreover, we determined mRNA and protein levels of sarco-endoplasmic reticulum calcium ATPase-2a (SERCA-2a), which is involved in calcium handling during contractility of cardiomyocytes in WT, Akita, and DKO hearts using QPCR, Western blotting and immunoprecipitation, respectively. Our results revealed that in Akita hearts where increased expression and activity of MMP9 is reported, the rates of shortening and re-lengthening (±dL/dt) of cardiomyocytes were decreased, time to 90% peak height and baseline during contractility was increased, rate of calcium decay was increased, and calcium transient was decreased as compared to WT cardiomyocytes. However, these changes in Akita were blunted in DKO cardiomyocytes. The molecular analyses of SERCA-2a in the hearts showed that it was downregulated in Akita as compared to WT but was comparatively upregulated in DKO. These results suggest that abrogation of MMP9 gene prevents contractility of cardiomyocytes, possibly by increasing SERCA-2a and calcium transients. We conclude that MMP9 plays a crucial role in the regulation of contractility of cardiomyocytes in diabetic hearts.
糖尿病心脏中已证实基质金属蛋白酶-9(MMP9)的表达和活性升高,且心肌细胞收缩性降低。然而,MMP是否参与糖尿病心脏中心肌细胞收缩性的调节尚不清楚。在本研究中,我们检验了以下假设:MMP9调节糖尿病心脏中心肌细胞的收缩性,敲除MMP9可预防糖尿病心脏中心肌细胞收缩性受损。为确定MMP9在心肌细胞收缩性中的具体作用,我们使用了12 - 14周龄的雄性野生型(秋田犬血糖正常的同窝小鼠)、秋田犬和Ins(2+∕-)/MMP9(-∕-)(双敲除,DKO)小鼠。DKO小鼠是通过将雄性Ins2(+∕-)秋田犬(1型糖尿病,T1D)与雌性MMP9基因敲除(MMP9(-∕-))小鼠杂交产生的。我们从上述三组小鼠的心脏中分离出心肌细胞,并测量它们的收缩性和钙瞬变。此外,我们分别使用定量聚合酶链反应(QPCR)、蛋白质免疫印迹法和免疫沉淀法,测定了肌浆网钙ATP酶-2a(SERCA-2a)的mRNA和蛋白质水平,SERCA-2a参与野生型、秋田犬和DKO心脏中心肌细胞收缩过程中的钙处理。我们的结果显示,在已报道MMP9表达和活性增加的秋田犬心脏中,与野生型心肌细胞相比,心肌细胞的缩短和再延长速率(±dL/dt)降低,收缩过程中达到90%峰值高度和基线的时间增加,钙衰减速率增加,钙瞬变降低。然而,秋田犬心脏中的这些变化在DKO心肌细胞中减弱。心脏中SERCA-2a的分子分析表明,与野生型相比,秋田犬心脏中SERCA-2a下调,但在DKO心脏中相对上调。这些结果表明,敲除MMP9基因可能通过增加SERCA-2a和钙瞬变来预防心肌细胞的收缩性。我们得出结论,MMP9在糖尿病心脏中心肌细胞收缩性的调节中起关键作用。